PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.\', \'Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.\', \'Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA.\', \'Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA. hieken.tina@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1245/s10434-021-10385-4
?:doi
?:hasPublicationType
?:journal
  • Annals of surgical oncology
is ?:pmid of
?:pmid
?:pmid
  • 34275042
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.986
?:rankingScore_hIndex
  • 149
is ?:relation_isRelatedTo_publication of
?:title
  • Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34275042>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34275042>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all